Cite
HARVARD Citation
Kolijn, D. et al. (2021). Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation. Cardiovascular research. 117 (2), pp. 495-507. [Online].